Search Results

Remdesivir alleviates skin fibrosis by suppressing TGF-[beta]1 signaling pathway

• Authors : Zhang, Jianwei; Zhang, Xiujun; Guo, Xiaowei

• Source: PLoS ONE. July 18, 2024, Vol. 19 Issue 7, pe0305927.

Record details

Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.

• Authors : Gonzalez Suarez, Maria Lourdes; Mara, Kristin C.; Rivera, Christina G.

Subjects: COVID-19; KIDNEY physiology; HOSPITAL patients

• Source: PLoS ONE; 6/14/2024, Vol. 19 Issue 6, p1-10, 10p

Record details

Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.

• Authors : Hussain Alsayed, Hawra Ali¹ (AUTHOR); Saheb Sharif-Askari, Fatemeh² (AUTHOR); Saheb Sharif-Askari, Narjes² (AUTHOR)

Subjects: *COVID-19; *REMDESIVIR; *COVID-19 treatment

• Source: PLoS ONE. 10/26/2021, Vol. 16 Issue 10, p1-10. 10p.

Record details

Remdesivir does not affect mitochondrial DNA copy number or deletion mutation frequency in aged male rats: A short report.

• Authors : Herbst, Allen; Choi, Solbie; Hoang, Austin N.

Subjects: DELETION mutation; MITOCHONDRIAL DNA; REMDESIVIR

• Source: PLoS ONE; 10/26/2022, Vol. 17 Issue 10, p1-11, 11p

Record details

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir.

• Authors : Torii, Shiho¹ (AUTHOR); Kim, Kwang Su² (AUTHOR); Koseki, Jun³ (AUTHOR)

Subjects: *REMDESIVIR; *SARS-CoV-2; *REVERSE genetics

• Source: PLoS Pathogens. 3/27/2023, Vol. 18 Issue 3, p1-23. 23p.

Record details

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.

• Authors : Béraud, Guillaume¹ (AUTHOR) ; Timsit, Jean-François^2,3 (AUTHOR); Leleu, Henri⁴ (AUTHOR)

Subjects: *REMDESIVIR; *HOSPITAL care; *INTENSIVE care unitsFRANCE

• Source: PLoS ONE. 1/12/2022, Vol. 17 Issue 1, p1-14. 14p.

Record details

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.

• Authors : Gressens, Simon B.¹ (AUTHOR) ; Esnault, Violaine¹ (AUTHOR); De Castro, Nathalie¹ (AUTHOR)

Subjects: *COVID-19; *REMDESIVIR; *HOSPITAL mortality

• Source: PLoS ONE. 2/17/2022, Vol. 17 Issue 2, p1-12. 12p.

Record details

Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.

• Authors : Pischel, Lauren^1,2,3 (AUTHOR) ; Walelo, Makeda⁴ (AUTHOR); Benson, Jemma⁵ (AUTHOR)

Subjects: *REMDESIVIR; *ELECTRONIC health records; *ETHNIC groups

• Source: PLoS ONE. 5/6/2021, Vol. 16 Issue 5, p1-9. 9p.

Record details

Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use.

• Authors : Kiptanui, Zippora¹ (AUTHOR) ; Ghosh, Sanchari² (AUTHOR); Ali, Sabeen² (AUTHOR)

Subjects: *COVID-19; *REMDESIVIR; *HEALTH equityWASHINGTON (D.C.)

• Source: PLoS ONE. 10/18/2021, Vol. 16 Issue 10, p1-12. 12p.

Record details

Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study.

• Authors : Tejada, Diana^1,2 (AUTHOR); Juanbeltz, Regina^1,2,3 (AUTHOR) ; Rivero, María^2,4 (AUTHOR)

Subjects: *COVID-19; *REMDESIVIR; *LENGTH of stay in hospitals

• Source: PLoS ONE. 4/28/2022, Vol. 17 Issue 4, p1-15. 15p.

Record details